Interferon-λ (IFN-λ) curbs neutrophil-mediated intestinal inflammation by diminishing the production of reactive oxygen species and subsequent oxidative stress. This regulatory process is unique to IFN-λ and is independent of interferon-induced transcription and translation programs.
References
Kolaczkowska, E. & Kubes, P. Nat. Rev. Immunol. 13, 159–175 (2013).
Broggi, A. Nat. Immunol. 18, 1084–1093 (2017).
Trinchieri, G. J. Exp. Med. 207, 2053–2063 (2010).
Kotenko, S.V. et al. Nat. Immunol. 4, 69–77 (2003).
Sheppard, P. et al. Nat. Immunol. 4, 63–68 (2003).
Sommereyns, C., Paul, S., Staeheli, P. & Michiels, T. PLoS Pathog. 4, e1000017 (2008).
McFarland, A.P. et al. Nat. Immunol. 15, 72–79 (2014).
Bolen, C.R., Ding, S., Robek, M.D. & Kleinstein, S.H. Hepatology 59, 1262–1272 (2014).
Jilg, N. et al. Hepatology 59, 1250–1261 (2014).
Davidson, S. et al. EMBO Mol. Med. 8, 1099–1112 (2016).
Galani, I.E. et al. Immunity 46, 875–890 (2017).
Blazek, K. et al. J. Exp. Med. 212, 845–853 (2015).
Odendall, C. et al. Nat. Immunol. 15, 717–726 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hemann, E., Schwerk, J. & Savan, R. IFN-λ 'guts' neutrophil-mediated inflammation. Nat Immunol 18, 1061–1062 (2017). https://doi.org/10.1038/ni.3834
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3834
- Springer Nature America, Inc.